AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26095381 — intervention group
Group type: COMPARATOR
Intervention: Nonbuffered 4% articaine with 1:100,000 epinephrine
Number of subjects: 80
Study 23220077 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day water-only fast
Number of subjects: 30
Study 21740600 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal goniometer
Number of subjects: 7
Study 21740600 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic inclinometer
Number of subjects: 7
Study 19095862 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Scope
Number of subjects: 100
Study 19095862 — intervention group
Group type: COMPARATOR
Intervention: StyletScope
Number of subjects: 100
Study 16480350 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg.kg(‐1) methylprednisolone
Number of subjects: 34
Study 16480350 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 34
Study 15219505 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 100
Study 15219505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 100
Study 11963730 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin during acute therapy of AMI
Number of subjects: 22697
Study 11963730 — intervention group
Group type: COMPARATOR
Intervention: No heparin during acute therapy of AMI
Number of subjects: 22697
Study 11963730 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin with fibrinolysis
Number of subjects: 22697
Study 11963730 — intervention group
Group type: COMPARATOR
Intervention: No heparin with fibrinolysis
Number of subjects: 22697
Study 9828755 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOred
Number of subjects: 8
Study 9828755 — intervention group
Group type: EXPERIMENTAL
Intervention: FATred
Number of subjects: 8
Study 9828755 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 8
Study 7656462 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin-dependent diabetes mellitus
Number of subjects: 200
Study 7656462 — intervention group
Group type: COMPARATOR
Intervention: Control group (sex- and age-matched)
Number of subjects: 200
Study 2566219 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS)
Number of subjects: 38
Study 2566219 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-Track (FPNVS)
Number of subjects: 38
Study 2566219 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine injection (increasing concentration)
Number of subjects: 38
Study 2566219 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine injection (decreasing concentration)
Number of subjects: 38
Study 2566219 — intervention group
Group type: EXPERIMENTAL
Intervention: Flare measurement
Number of subjects: 38
Study 827779 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (50 mg)
Number of subjects: 0
Study 827779 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine (50 mg)
Number of subjects: 0
Study 827779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7034467 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Care
Number of subjects: 0
Study 7034467 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study 31726990 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpreter proxy
Number of subjects: 85
Study 31726990 — intervention group
Group type: COMPARATOR
Intervention: Certified healthcare interpreter
Number of subjects: 85
Study 29388532 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception study using food photos for portion estimation
Number of subjects: 365
Study 29388532 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory study using food photos for portion estimation
Number of subjects: 365
Study 26810496 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable, custom-made oral appliance (Narval®) without elastic bands
Number of subjects: 10
Study 26810496 — intervention group
Group type: COMPARATOR
Intervention: Adjustable, custom-made oral appliance (Narval®) with elastic bands
Number of subjects: 10
Study 26810496 — intervention group
Group type: COMPARATOR
Intervention: Subjects with severe OSA using elastic bands
Number of subjects: 10
Study 26810496 — intervention group
Group type: COMPARATOR
Intervention: Overall preference of patients
Number of subjects: 10
Study 25209323 — intervention group
Group type: EXPERIMENTAL
Intervention: Action 3:30 intervention (40 one-hour sessions, delivered twice a week by teaching assistants)
Number of subjects: 20
Study 25209323 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 schools)
Number of subjects: 20
Study 25209323 — intervention group
Group type: EXPERIMENTAL
Intervention: Action 3:30 intervention
Number of subjects: 20
Study 21831453 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-assisted social cognitive training (F-SCIT) once a week for 14 weeks
Number of subjects: 0
Study 21831453 — intervention group
Group type: COMPARATOR
Intervention: Social stimulation (SS) once every three weeks for 14 weeks
Number of subjects: 0
Study 20173480 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter removed on postoperative day 1 (Group A)
Number of subjects: 118
Study 20173480 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter removed on postoperative day 3 (Group B)
Number of subjects: 118
Study 20173480 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter removed on postoperative day 5 (Group C)
Number of subjects: 118
Study 17018708 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOEP (CHOP+etoposide)
Number of subjects: 1693
Study 17018708 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal prophylaxis
Number of subjects: 1693
Study 17018708 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy (CHOP-21, CHOP-14)
Number of subjects: 1693
Study 17018708 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased LDH and involvement of more than one extranodal site
Number of subjects: 1693
Study 17018708 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly patients with elevated LDH and extranodal involvement
Number of subjects: 1693
Study 16326641 — intervention group
Group type: EXPERIMENTAL
Intervention: PALM-diet
Number of subjects: 27
Study 16326641 — intervention group
Group type: COMPARATOR
Intervention: TRANS-diet
Number of subjects: 27
Study 16326641 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFA-diet
Number of subjects: 27
Study 12391522 — intervention group
Group type: EXPERIMENTAL
Intervention: NasOral((R)) system
Number of subjects: 40
Study 12391522 — intervention group
Group type: COMPARATOR
Intervention: Face mask with O(2) flow of 15 l/min
Number of subjects: 40
Study 10445069 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental appliance
Number of subjects: 95
Study 10445069 — intervention group
Group type: COMPARATOR
Intervention: UPPP
Number of subjects: 95
Study 7597662 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphoramidon (10(‐5) M, 3 ml)
Number of subjects: 10
Study 7597662 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphoramidon
Number of subjects: 10
Study 7597662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2205358 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 480 mg/day
Number of subjects: 40
Study 2205358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2205358 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA)
Number of subjects: 40
Study 761002 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mtechnetium-labelled red-cell venous pool scanning
Number of subjects: 32
Study 761002 — intervention group
Group type: COMPARATOR
Intervention: Conventional x-ray phlebography
Number of subjects: 32
Study 31958907 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1,000 mg/day)
Number of subjects: 0
Study 31958907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30311850 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-facilitated cognitive behavioral therapy (Mom-Net)
Number of subjects: 336
Study 30311850 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 336
Study 30311850 — intervention group
Group type: COMPARATOR
Intervention: Motivational interviewing and referral to services
Number of subjects: 336
Study 28182706 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly $70 gift card financial incentives
Number of subjects: 72
Study 25817108 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm ischemia
Number of subjects: 120
Study 25817108 — intervention group
Group type: COMPARATOR
Intervention: Cold ischemia
Number of subjects: 120
Study 24250317 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain use after thyroidectomy
Number of subjects: 68
Study 24250317 — intervention group
Group type: COMPARATOR
Intervention: No drain after thyroidectomy
Number of subjects: 68
Study 21358565 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 237
Study 21358565 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraversion
Number of subjects: 237
Study 21358565 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreeableness
Number of subjects: 237
Study 21358565 — intervention group
Group type: COMPARATOR
Intervention: Context knowledge, context experience, and other personality traits
Number of subjects: 237
Study 19554002 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise program
Number of subjects: 0
Study 19554002 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 16804289 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment
Number of subjects: 80
Study 16804289 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 80
Study 16804289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with OSAS before CPAP treatment
Number of subjects: 80
Study 15495826 — intervention group
Group type: EXPERIMENTAL
Intervention: Cs A + pred + BLC
Number of subjects: 121
Study 15495826 — intervention group
Group type: COMPARATOR
Intervention: Cs A + pred + azathioprine (Aza)
Number of subjects: 121
Study 11597850 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom teaching supplemented with Internet-based discussions (Internet component group)
Number of subjects: 127
Study 11597850 — intervention group
Group type: COMPARATOR
Intervention: Classroom teaching alone (traditional group)
Number of subjects: 127
Study 9230238 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 200 microg x day(-1)
Number of subjects: 48
Study 9230238 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg x day(-1)
Number of subjects: 48
Study 9230238 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 microg)
Number of subjects: 48
Study 9230238 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg x day(-1)
Number of subjects: 48
Study 9230238 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 400 microg x day(-1)
Number of subjects: 48
Study 9230238 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 microg)
Number of subjects: 48
Study 7975415 — intervention group
Group type: EXPERIMENTAL
Intervention: Element diet
Number of subjects: 19
Study 7975415 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 19
Study 3548637 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride (134 +/- 33 mg/d)
Number of subjects: 29
Study 3548637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 30724853 — intervention group
Group type: COMPARATOR
Intervention: Conventional DAPT
Number of subjects: 1327
Study 30724853 — intervention group
Group type: COMPARATOR
Intervention: Prospective genotyping-guided DAPT
Number of subjects: 1327
Study 28864691 — intervention group
Group type: EXPERIMENTAL
Intervention: RDN using 5F saline‐irrigated radiofrequency ablation (RFA) plus antihypertensive medication
Number of subjects: 254
Study 28864691 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive medication alone
Number of subjects: 254
Study 26004401 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative oxygen
Number of subjects: 226
Study 26004401 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 226
Study 23195627 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart transplant recipients (HTRs)
Number of subjects: 6
Study 23195627 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (CTL)
Number of subjects: 6
Study 20950844 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (Group AII and Group BII)
Number of subjects: 60
Study 20950844 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (Group AII)
Number of subjects: 60
Study 20950844 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (Group BII)
Number of subjects: 60
Study 18814217 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple-use TAXUS stent (on-label)
Number of subjects: 2487
Study 18814217 — intervention group
Group type: COMPARATOR
Intervention: Expanded use TAXUS stent
Number of subjects: 2487
Study 16051211 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal spatial and temporal structure
Number of subjects: 0
Study 16051211 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambled spatial and normal temporal structure
Number of subjects: 0
Study 16051211 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal spatial and scrambled temporal structure
Number of subjects: 0
Study 16051211 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambled spatial and temporal structure
Number of subjects: 0
Study 13679934 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin (ALB)
Number of subjects: 41
Study 13679934 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 41
Study 11023499 — intervention group
Group type: EXPERIMENTAL
Intervention: Detectable MRD (ie, > or = 0.01% leukemic mononuclear cells) at each time point
Number of subjects: 195
Study 11023499 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of MRD at the end of the induction phase (> or = 1%) or at week 14 of continuation therapy (> or = 0.1%)
Number of subjects: 195
Study 11023499 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD at the end of the induction phase
Number of subjects: 195
Study 11023499 — intervention group
Group type: COMPARATOR
Intervention: MRD became undetectable
Number of subjects: 195
Study 11023499 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistence of MRD until week 32
Number of subjects: 195
Study 8612107 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1800 mg per day)
Number of subjects: 25
Study 8612107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 1595324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 IU.kg‐1.week‐1 hGH
Number of subjects: 46
Study 1595324 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 IU.kg‐1.week‐1 hGH
Number of subjects: 46
Study 1595324 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 46
Study 6096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan fiber (1-g doses, two 500 mg capsules with 8 oz water, 1 h prior to each meal)
Number of subjects: 20
Study 6096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan fiber
Number of subjects: 20
Study 6096282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31714253 — intervention group
Group type: EXPERIMENTAL
Intervention: Online recruitment methods
Number of subjects: 655
Study 31714253 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment methods
Number of subjects: 655
Study 31714253 — intervention group
Group type: EXPERIMENTAL
Intervention: Online recruitment (Gumtree)
Number of subjects: 655
Study 31714253 — intervention group
Group type: EXPERIMENTAL
Intervention: Online recruitment (email)
Number of subjects: 655
Study 31714253 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (Women)
Number of subjects: 655
Study 29454678 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg CoQ10 daily for 24 weeks
Number of subjects: 101
Study 29454678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 25426516 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise at 0700 hours (7A)
Number of subjects: 9
Study 25426516 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise at 1300 hours (1P)
Number of subjects: 9
Study 25426516 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise at 1900 hours (7P)
Number of subjects: 9
Study 25426516 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (7A, 1P, 7P)
Number of subjects: 9
Study 25426516 — intervention group
Group type: COMPARATOR
Intervention: Non-Resistance Exercise Control (C)
Number of subjects: 9
Study 23293082 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab + Dexamethasone (40 mg/day for 4 days and 375 mg/m² weekly for 4 weeks)
Number of subjects: 133
Study 23293082 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (40 mg/day for 4 days)
Number of subjects: 133
Study 23293082 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab + Dexamethasone
Number of subjects: 133
Study 21624649 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (15 days with tapering schedule) plus oral amoxicillin/clavulanate (AMX/C)
Number of subjects: 48
Study 21624649 — intervention group
Group type: COMPARATOR
Intervention: Oral amoxicillin/clavulanate (AMX/C) plus placebo
Number of subjects: 48
Study 19372358 — intervention group
Group type: EXPERIMENTAL
Intervention: C7 landmark
Number of subjects: 210
Study 19372358 — intervention group
Group type: COMPARATOR
Intervention: Scapular landmark
Number of subjects: 210
Study 16456411 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepackaged diet kit plus magnesium citrate/bisacodyl laxative (group 1)
Number of subjects: 62
Study 16456411 — intervention group
Group type: COMPARATOR
Intervention: Clear liquids and sodium phosphate solution (group 2)
Number of subjects: 62
Study 14671241 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with occipital lobe infarct
Number of subjects: 47
Study 14671241 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 47
Study 11816867 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (40 weeks of double-blind continuation-phase therapy)
Number of subjects: 410
Study 11816867 — intervention group
Group type: COMPARATOR
Intervention: Placebo (40 weeks of double-blind continuation-phase therapy)
Number of subjects: 410
Study 7970537 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healon)
Number of subjects: 107
Study 7970537 — intervention group
Group type: COMPARATOR
Intervention: Control (no Healon)
Number of subjects: 107
Study 3630598 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective blanket
Number of subjects: 28
Study 3630598 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating humidifier of inhaled gases
Number of subjects: 28
Study 3630598 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both techniques
Number of subjects: 28
Study 3630598 — intervention group
Group type: COMPARATOR
Intervention: No prevention at all
Number of subjects: 28
Study 29338585 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based media literacy curriculum (six-session curriculum)
Number of subjects: 100
Study 27594150 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy combined with treatment for ameliorating the PE symptom (oral dapoxetine on-demand and ejaculation control exercise)
Number of subjects: 90
Study 27594150 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (oral administration of antibiotics, α-receptor blocker, and proprietary Chinese medicine)
Number of subjects: 90
Study 25751697 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSRthr (auditory steady-state response threshold)
Number of subjects: 24
Study 25751697 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSRthr
Number of subjects: 24
Study 23868273 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg intravenously, administered 12 hourly for a total of 5 doses
Number of subjects: 95
Study 23868273 — intervention group
Group type: COMPARATOR
Intervention: No minocycline (control)
Number of subjects: 95
Study 23868273 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of minocycline across 3 human trials
Number of subjects: 95
Study 20082104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (Aluminum gallium arsenide laser, 785 nm, 3 J/cm², 70 mW)
Number of subjects: 82
Study 20082104 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 82
Study 18194335 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic polyphosphate
Number of subjects: 33
Study 18194335 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study 16474990 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention provided between ages 0 and 3
Number of subjects: 985
Study 16474990 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without verbal LD)
Number of subjects: 985
Study 12816140 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) restorations
Number of subjects: 89
Study 12816140 — intervention group
Group type: COMPARATOR
Intervention: Conventional amalgam restorations
Number of subjects: 89
Study 11388500 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroderivative therapy
Number of subjects: 91
Study 11388500 — intervention group
Group type: COMPARATOR
Intervention: Untreated Chagas patients
Number of subjects: 91
Study 11388500 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated Chagas patients
Number of subjects: 91
Study 11388500 — intervention group
Group type: EXPERIMENTAL
Intervention: Chagas patients (treated and untreated)
Number of subjects: 91
Study 9356879 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 300 mg i.v. bolus followed by 300 mg i.v. every 6 hr during hospitalization
Number of subjects: 52
Study 9356879 — intervention group
Group type: COMPARATOR
Intervention: Heater probe thermocoagulation + cimetidine 300 mg i.v. bolus followed by 300 mg i.v. every 6 hr during hospitalization
Number of subjects: 52
Study 9356879 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg i.v. bolus followed by 40 mg i.v. daily for two days
Number of subjects: 52